Medical Retina Department, NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital, London, UK
Vision Sciences, UCL, London, UK.
BMJ Open. 2021 Jun 28;11(6):e040577. doi: 10.1136/bmjopen-2020-040577.
Using a type 2 hybrid effectiveness-implementation design, we aim to pilot a diabetic retinopathy (DR) care pathway in the public health system in Kerala to understand how it can be scaled up to and sustained in the whole state.
Currently, there is no systematic DR screening programme in Kerala. Our intervention is a teleophthalmology pathway for people with diabetes in the non-communicable disease registers in 16 family health centres. The planned implementation strategy of the pathway will be developed based on the discrete Expert Recommendations for Implementing Change taxonomy. We will use both quantitative data from a cross-sectional study and qualitative data obtained from structured interviews, surveys and group discussions with stakeholders to report the effectiveness of the DR care pathway and evaluation of the implementation strategy.We will use logistic regression models to assess crude associations DR and sight-threatening diabetic retinopathy and fractional polynomials to account for the form of continuous covariates to predict uptake of DR screening. The primary effectiveness outcome is the proportion of patients in the non-communicable disease register with diabetes screened for DR over 12 months. Other outcomes include cost-effectiveness, safety, efficiency, patient satisfaction, timeliness and equity. The outcomes of evaluation of the implementation strategies include acceptability, feasibility, adoption, appropriateness, fidelity, penetration, costs and sustainability. Addition of more family health centres during the staggered initial phase of the programme will be considered as a sign of acceptability and feasibility. In the long term, the state-wide adoption of the DR care pathway will be considered as a successful outcome of the Nayanamritham study.
The study was approved by Indian Medical Research Council (2018-0551) dated 13 March 2019. Study findings will be disseminated through scientific publications and the report will inform adoption of the DR care pathway by Kerala state in future.
ISRCTN28942696.
本研究采用 2 型混合效果-实施设计,旨在为喀拉拉邦的公共卫生系统试点糖尿病视网膜病变(DR)护理途径,以了解如何将其扩展并维持在整个邦。
目前,喀拉拉邦没有系统的 DR 筛查计划。我们的干预措施是在 16 个家庭健康中心的非传染性疾病登记处为糖尿病患者提供远程眼科护理途径。途径的计划实施策略将基于离散专家推荐实施变革分类法制定。我们将使用横断面研究的定量数据和来自利益相关者的结构化访谈、调查和小组讨论获得的定性数据来报告 DR 护理途径的有效性和实施策略的评估。我们将使用逻辑回归模型评估 DR 和威胁视力的糖尿病性视网膜病变的粗关联,并使用分数多项式来解释连续协变量的形式,以预测 DR 筛查的接受率。主要有效性结果是在 12 个月内接受糖尿病非传染性疾病登记处 DR 筛查的患者比例。其他结果包括成本效益、安全性、效率、患者满意度、及时性和公平性。实施策略评估的结果包括可接受性、可行性、采用、适当性、保真度、渗透性、成本和可持续性。在该计划的交错初始阶段增加更多的家庭健康中心将被视为可接受性和可行性的标志。从长远来看,DR 护理途径在全州范围内的采用将被视为 Nayanamritham 研究的成功结果。
该研究已获得印度医学研究理事会(2018-0551)的批准(日期为 2019 年 3 月 13 日)。研究结果将通过科学出版物传播,报告将为喀拉拉邦未来采用 DR 护理途径提供信息。
ISRCTN28942696。